Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03822962 · ClinicalTrials.gov registry record · Early Phase 1
Pain Management Following Sinus Surgery
A Early Phase 1 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT03822962 is a Early Phase 1 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 10 participants.
The verdict
NCT03822962, a Early Phase 1 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This Study evaluates the effect of adding Non-steroidal anti-inflammatories (NSAIDs) to the post-operative pain management of sinus surgery patients and wether or not this addition reduces or eliminates the need for narcotic pain medications. Patients will be instructed to take an NSAID regimen after surgery and will be instructed to take narcotics only for breakthrough pain.
Interventions
- DRUG Ibuprofen 600Mg Tablet
- OTHER Standard Regimen | Tylenol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-11-07 |
| Est. Completion | 2023-05-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03822962
The ClinicalTrials.gov registry entry for NCT03822962 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen 600Mg Tablet is the first listed.
NCT03822962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03822962 about?
NCT03822962 is a clinical study titled "Pain Management Following Sinus Surgery". This Study evaluates the effect of adding Non-steroidal anti-inflammatories (NSAIDs) to the post-operative pain management of sinus surgery patients and wether or not this addition reduces or eliminates the need for narcotic pain medications. Patients will be instructed to take an NSAID regimen aft...
What is the current status of trial NCT03822962?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2020-11-07. Estimated completion is 2023-05-30.
What interventions are being tested in trial NCT03822962?
The interventions under investigation include: Ibuprofen 600Mg Tablet (DRUG), Standard Regimen | Tylenol (OTHER).
Who is sponsoring clinical trial NCT03822962?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.